Concepedia

L. Adam

LA

Statistics

Publications

7

Citations

502

H-Index

7

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Newcastle University

L. Adam is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1991–2017

7

Publications

7

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

Evelyn Jaros, R.H. Perry, L. Adam et al. · British Journal of Cancer · 1992 · 264 citations · Full text

, , +17

Loss of AP-2α results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo

Betty Schwartz, Vladislava O. Melnikova, Carmen S. Tellez et al. · Oncogene · 2007 · 74 citations

, , +14

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer

Michael J. Overman, L. Adam, Kanwal Raghav et al. · Annals of Oncology · 2017 · 55 citations · Full text

, , +14

Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells

Ran Song, Richard J. Santen, Rakesh Kumar et al. · Molecular and Cellular Endocrinology · 2002 · 38 citations

, , +16

Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.

L. Adam, M Crépin, Lucien Israël · PubMed · 1997 · 38 citations

, , +17

1–5 of 7